A Study in Relapse Prevention of Treatment-Resistant Depression
Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether olanzapine and fluoxetine combination (OFC)
if used for a long time (47 weeks) makes patients suffering from Treatment Resistant
Depression stable, determine if OFC is safe when used to treat patients with Treatment
Resistant Depression for a long time (up to 47 weeks), to determine whether olanzapine and
fluoxetine combination or fluoxetine alone is better to treat Treatment Resistant Depression
when treated for a long time (up to 47 weeks) and to assess the quality of life during
treatment.